Statera BioPharma Overview

Statera BioPharma Research & Development

Research & Development expenses for STAB.

Quarterly R&D Expenses

$230604.00

↓ 93.29% YoY

As of Sep 30, 2022

Annual R&D Expenses (TTM)

$12.67M

↑ 234.38% YoY

Trailing 12 months ending Sep 30, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin